Thomas Hayman is an Oncology physician affiliated with Yale University. OpenAlex indexes 50 publications with 869 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:
- Tumor-Targeted STING Agonism in Head and Neck Squamous Cell Carcinoma
Yale University
FY2026$482,918R37CA295952 - Tumor-Targeted STING Agonism in Head and Neck Squamous Cell Carcinoma
Yale University
FY2025$499,238R37CA295952
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”